GHP Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

GHP Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.05M	Hold	60,364	–	–	0.08%	240
2026 Q1	$1.82M	Buy	60,364 +9,480	+19%	+$305K	0.07%	238
2025 Q4	$1.59M	Hold	50,884	–	–	0.07%	246
2025 Q3	$1.03M	Hold	50,884	–	–	0.04%	274
2025 Q2	$853K	Hold	50,884	–	–	0.04%	278
2025 Q1	$782K	Buy	50,884 +18,819	+59%	+$336K	0.04%	277
2024 Q4	$707K	Hold	32,065	–	–	0.03%	283
2024 Q3	$578K	Buy	32,065 +30,265	+1,681%	+$530K	0.03%	293
2024 Q2	$29.3K	Hold	1,800	–	–	﹤0.01%	548
2024 Q1	$25.4K	Sell	1,800 -200	-10%	-$2.52K	﹤0.01%	556
2023 Q4	$20.9K	Hold	2,000	–	–	﹤0.01%	566
2023 Q3	$17.3K	Hold	2,000	–	–	﹤0.01%	618
2023 Q2	$19.6K	Sell	2,000 -400	-17%	-$3.24K	﹤0.01%	589
2023 Q1	$21.2K	Hold	2,400	–	–	﹤0.01%	578
2022 Q4	$21.9K	Hold	2,400	–	–	﹤0.01%	571
2022 Q3	$19K	Hold	2,400	–	–	﹤0.01%	585
2022 Q2	$18K	Hold	2,400	–	–	﹤0.01%	591
2022 Q1	$23K	Buy	+2,400	New	+$20K	﹤0.01%	591
2019 Q2	–	Sell	-26,023	Closed	-$408K	–	310
2019 Q1	$408K	Buy	26,023 +4,300	+20%	+$75.8K	0.05%	238
2018 Q4	$335K	Sell	21,723 -200	-0.9%	-$4.1K	0.05%	247
2018 Q3	$472K	Buy	21,923 +620	+3%	+$14.4K	0.06%	228
2018 Q2	$518K	Hold	21,303	–	–	0.07%	225
2018 Q1	$364K	Hold	21,303	–	–	0.05%	245
2017 Q4	$404K	Buy	21,303 +7,750	+57%	+$117K	0.06%	242
2017 Q3	$239K	Buy	13,553 +200	+1%	+$4.5K	0.04%	273
2017 Q2	$444K	Buy	13,353 +3,030	+29%	+$93.8K	0.07%	236
2017 Q1	$331K	Hold	10,323	–	–	0.06%	256
2016 Q4	$374K	Hold	10,323	–	–	0.07%	239
2016 Q3	$475K	Buy	10,323 +500	+5%	+$26.1K	0.1%	212
2016 Q2	$493K	Hold	9,823	–	–	0.11%	205
2016 Q1	$526K	Sell	9,823 -400	-4%	-$23.5K	0.12%	197
2015 Q4	$671K	Sell	10,223 -152	-1%	-$9.39K	0.16%	157
2015 Q3	$586K	Hold	10,375	–	–	0.15%	163
2015 Q2	$642K	Hold	10,375	–	–	0.16%	156
2015 Q1	$646K	Buy	10,375 +170	+2%	+$9.88K	0.17%	153
2014 Q4	$587K	Sell	10,205 -150	-1%	-$8.36K	0.16%	152
2014 Q3	$557K	Buy	10,355 +60	+0.6%	+$3.18K	0.16%	151
2014 Q2	$540K	Hold	10,295	–	–	0.16%	153
2014 Q1	$544K	Buy	10,295 +240	+2%	+$11.1K	0.17%	144
2013 Q4	$403K	Sell	10,055 -400	-4%	-$15.8K	0.13%	174
2013 Q3	$395K	Hold	10,455	–	–	0.14%	169
2013 Q2	$410K	Buy	+10,455	New	+$407K	0.16%	156

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GHP Investment Advisors's TEVA Position: Q2 2026 in Review

GHP Investment Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 60,364 shares worth $2.05M. The position accounts for 0.08% of the portfolio, ranked #240.

GHP Investment Advisors first reported a position in TEVA in Q2 2013 and has held it in 42 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

GHP Investment Advisors held 60,364 shares of Teva Pharmaceuticals worth $2.05M as of Q2 2026.
GHP Investment Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.08% of GHP Investment Advisors's portfolio in Q2 2026, its #240 holding.
GHP Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.